These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34520765)

  • 1. Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.
    Zheng X; Yang Y; Huang Fu C; Huang R
    Life Sci; 2021 Nov; 285():119956. PubMed ID: 34520765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
    Zhao W; Wu T; Zhan J; Dong Z
    Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.
    Zhang XZ; Zhang S; Tang TT; Cheng X
    Front Cardiovasc Med; 2021; 8():696321. PubMed ID: 34497835
    [No Abstract]   [Full Text] [Related]  

  • 4. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
    Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
    Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
    Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
    J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.
    Ma Z; Wang X; Lv Q; Gong Y; Xia M; Zhuang L; Lu X; Yang Y; Zhang W; Fu G; Ye Y; Lai D
    Pharmgenomics Pers Med; 2021; 14():823-837. PubMed ID: 34285551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.
    Yu T; Huang Z; Pu Z
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.
    Kong C; Zhu Y; Xie X; Wu J; Qian M
    Front Immunol; 2023; 14():1184700. PubMed ID: 37359526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.
    Guo L; Cai Y; Wang B; Zhang F; Zhao H; Liu L; Tao L
    Eur J Med Res; 2023 Jun; 28(1):205. PubMed ID: 37391825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteomodulin is a Potential Genetic Target for Hypertrophic Cardiomyopathy.
    Guo W; Feng W; Fan X; Huang J; Ou C; Chen M
    Biochem Genet; 2021 Oct; 59(5):1185-1202. PubMed ID: 33715137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm.
    Shen X; Yang Z; Feng S; Li Y
    World J Surg Oncol; 2021 Jul; 19(1):223. PubMed ID: 34321013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy.
    Cui Y; Liu C; Luo J; Liang J
    J Healthc Eng; 2022; 2022():8680178. PubMed ID: 35126952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
    He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
    Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.
    You H; Dong M
    J Int Med Res; 2023 Nov; 51(11):3000605231213781. PubMed ID: 38006610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis.
    Li C; Lu Y; Han X
    Front Mol Biosci; 2022; 9():917077. PubMed ID: 35911963
    [No Abstract]   [Full Text] [Related]  

  • 16. Unveiling Immune Infiltration Characterizing Genes in Hypertrophic Cardiomyopathy Through Transcriptomics and Bioinformatics.
    Gong J; Shi B; Yang P; Khan A; Xiong T; Li Z
    J Inflamm Res; 2024; 17():3079-3092. PubMed ID: 38774444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and exploration of novel M2 macrophage-related biomarkers in the development of acute myocardial infarction.
    Zhou Q; Zhang G; Liu Z; Zhang J; Shi R
    Front Cardiovasc Med; 2022; 9():974353. PubMed ID: 36440001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy.
    Li Y; Zhang W; Dai Y; Chen K
    Front Genet; 2022; 13():986995. PubMed ID: 36267414
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysfunctional network of hub genes in hypertrophic cardiomyopathy patients.
    Wu S; Ud Din I; Sadiq FM; Abdel-Maksoud MA; Haris M; Mubarak A; Farrag MA; Alghamdi S; Almekhlafi S; Akram M; Li G
    Am J Transl Res; 2022; 14(12):8918-8933. PubMed ID: 36628247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.